HDL and glucose metabolism: current evidence and therapeutic potential

High-density lipoprotein (HDL) and its principal apolipoprotein A-I (ApoA-I) have now been convincingly shown to influence glucose metabolism through multiple mechanisms. The key clinically relevant observations are that both acute HDL elevation via short-term reconstituted HDL (rHDL) infusion and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebel, Andrew L., Heywood, Sarah Elizabeth, Kingwell, Bronwyn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628107/
https://www.ncbi.nlm.nih.gov/pubmed/26582989
http://dx.doi.org/10.3389/fphar.2015.00258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628107/
https://www.ncbi.nlm.nih.gov/pubmed/26582989
http://dx.doi.org/10.3389/fphar.2015.00258

Ejemplares similares